Leerink Transformation Partners (LTP), a Boston, MA-based investor in innovative companies in the healthcare IT and services sectors, closed its maiden fund, at $313m.
Leerink Transformation Fund I LP focuses on growth equity investing in healthcare information technology and services companies and has already made investments in:
– Outcome Health,
– Scientist.com,
– Vera Whole Health,
– PatientPing,
– Health Catalyst, and
– Kyruus.
Founded in 2016 by Todd Cozzens and Jared Kesselheim, MD., who were previously healthcare investing at Sequoia Capital and Bain Capital Ventures, respectively, LTP also manages the Massachusetts Innovation Catalyst Fund I L.P. (MICF), a $28m fund, which co-invests alongside LTF I in Massachusetts-based companies.
Mr. Cozzens joined LTP from Sequoia Capital following a 25-year career as a founder and CEO in the healthcare technology and services industry taking one company, Marquette Medical, public and later sale to GE and another, Picis, to acquisition by UnitedHealth Group where he helped form Optum.
Dr. Kesselheim, a board-certified physician in internal medicine trained at Massachusetts General Hospital and holding a MD and MBA from Harvard, joined LTP after an 8-year career at Bain Capital Ventures, most recently leading their healthcare investing team.
FinSMEs
29/09/2017